Literature DB >> 6731291

"Left main equivalent" coronary artery disease: its clinical presentation and prognostic significance with nonsurgical therapy.

R M Califf, M J Conley, V S Behar, F E Harrell, K L Lee, D B Pryor, R A McKinnis, R A Rosati.   

Abstract

The clinical characteristics and nonsurgical prognosis of 55 patients with "left main (LM) equivalent" coronary artery disease (CAD) were evaluated and defined as: (1) greater than or equal to 75% diameter reduction of the left anterior descending coronary artery (LAD) before the takeoff of any large septal perforator or anterolateral (diagonal) branches; (2) greater than or equal to 75% diameter reduction of the left circumflex artery (LC) before the takeoff of any large marginal branch; and (3) absence of greater than or equal to 50% stenosis of the LM coronary artery. Compared with nonsurgically treated patients with greater than or equal to 75% stenosis of the LM artery, patients with LM equivalent CAD had a shorter duration of symptoms (median of 51 months vs 66 months) and more often had a Q wave on the electrocardiogram (60 vs 39%). Survival in patients with LM equivalent CAD (78% at 1 year and 55% at 5 years) was better than that in patients with LM disease with nonsurgical therapy (65% at 1 year and 40% at 5 years) (p = 0.02), although the rate of freedom from cardiovascular events was not significantly different. Compared with other nonsurgically treated patients with 2- or 3-vessel CAD involving the LAD and LC (28 and 42%, respectively, with progressive angina), patients with LM equivalent CAD had more severe anginal symptoms (55% with progressive angina) and a longer duration of symptoms (medians of 20 months in 2-vessel CAD, 36 months in 3-vessel CAD and 51 months in LM equivalent CAD).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6731291     DOI: 10.1016/0002-9149(84)90565-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  The Current State of Coronary Revascularization: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery.

Authors:  Matthew A Brown; Seth Klusewitz; John Elefteriades; Lindsey Prescher
Journal:  Int J Angiol       Date:  2021-11-10

2.  Validation of Scoring Systems That Predict Outcomes in Patients With Coronary Artery Disease Undergoing Coronary Artery Bypass Grafting Surgery.

Authors:  Wen-Jung Chung; Chung-Yu Chen; Fan-Yen Lee; Chia-Chen Wu; Shu-Kai Hsueh; Cheng-Jei Lin; Chi-Ling Hang; Chiung-Jen Wu; Cheng-I Cheng
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

Review 3.  What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?

Authors:  Colin Berry; Andrew J Morrow; Mario Marzilli; Carl J Pepine
Journal:  Cardiovasc Drugs Ther       Date:  2021-05-12       Impact factor: 3.947

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.